What Does "Beyond Standard of Care" Actually Mean in Cancer Care?
· Gena Health Team
When “standard” cancer treatments stop working, it’s natural to feel as if you’re in limbo - no longer in active treatment, yet working harder than ever to figure out what’s next. There are more appointments to chase, second opinions to request, and trial lists to scan. It can feel like your life has turned into a full-time research job.
Reaching the end of standard treatment doesn’t mean the end of options, it’s just the beginning of a different kind of work. This guide helps you understand what beyond standard of care means, and how to explore it safely and effectively.
What does “Standard of Care” actually mean?
In the NHS, standard of care refers to the established, evidence-based treatments that experts agree work best for a specific cancer and stage. It’s usually the most studied path (surgery, chemotherapy, radiotherapy, or a combination) and what’s typically recommended by experts or recommended for reimbursement by health authorities such as NICE in the UK. Doctors usually start with these proven treatments first. That being said, the standard of care from one country can vary significantly, which can lead to geographic disparities.
It’s important to remember that standard care is based on what works for most people, but every cancer case is unique. Standard of care evolves over time as new research emerges. What’s “standard” today might be replaced by a better therapy tomorrow if evidence shows improved outcomes. In fast-moving fields like oncology, new drugs and personalised therapies are constantly being tested, and some patients may benefit from these emerging options even before they become the new standard.
For rare cancers (generally defined as affecting fewer than 6 in 100,000 people per year), the standard of care is often limited or not as well defined, which makes it harder for patients and clinicians to find new options quickly.
What counts as “Beyond Standard of Care”?
“Beyond standard of care” in practice means any treatment approach that isn’t part of the typical first- or second-line regimen for your cancer. These options can include new therapies in clinical trials, off-label drug use, specialised programmes, or other innovative approaches. Options include:
Clinical trials, which test new treatments or new combinations of treatments that are not yet widely available. (See our Clinical Trials Demystified series to learn more about what it means to participate in clinical trials.)
Off-label or experimental options. Sometimes, drugs that are approved for a different cancer or condition (or not yet approved at all) might show promise for your diagnosis. Using a drug “off-label” means the medicine is legally available, just not officially approved for your specific cancer. In the UK, accessing such treatments often requires special arrangements such as the Early Access to Medicines Scheme (EAMS), the Cancer Drugs Fund (CDF) (in England), Individual Funding Requests (IFRs), or compassionate use programmes from pharmaceutical companies. Off-label and experimental treatments should always be discussed with your oncologist.
Private treatment and going abroad. If the NHS cannot provide a certain therapy, some patients consider paying privately or even travelling overseas for treatment. Before going private or abroad, NHS guidance encourages exploring funded routes first to avoid unnecessary duplication or costs.
Support from charities or specialist organisations. Organisations focused on your cancer type can help you find information and connect you with beyond-standard options — for example, Macmillan Cancer Support, or Brainstrust.
Working with your care team: how do you approach this topic?
Many patients worry about sounding “difficult” when raising new options. In reality, NHS oncologists are used to these conversations. Here are a few ways you could bring up the discussion with your doctor:
Could we review any open UK trials for my subtype?
Are there Cancer Drugs Fund or Early Access options for my situation?
Would an Individual Funding Request make sense for my case?
If we need a second opinion, which centre would you recommend?
How Gena Health Helps Patients Find Treatments Beyond Standard of Care
We know first-hand how overwhelming it is to navigate the world of non-standard treatment options and be your own researcher. We designed Gena to help patients and their clinicians uncover personalised treatment opportunities beyond what the standard NHS pathway might offer.
Compass is our free AI-powered navigator, which matches patients to treatments and clinical trials based on their medical history. To ensure the highest quality of care, we’re currently piloting the platform for glioblastoma patients but expanding quickly. [Learn more about Compass]
Final Thoughts
For people living with rare, advanced, or hard-to-treat cancers, the search for options beyond standard care can feel like stepping into uncharted territory. Information can be scattered, systems are complex, and waiting can be hard to bear. But with the right guidance and reliable information, you can go into discussions prepared and have an informed say in your own cancer care. At Gena, we’re guided by our values of empowerment, transparency, equity, and progress - helping you navigate your options with clarity and support, so you don’t have to do it alone.